Rachel Issaka

1 week ago | patientcareonline.com | Rachel Issaka |Grace Halsey

For many patients who are eligible for colorectal cancer screening, choosing the most suitable test is straightforward, but not for all, Rachel Issaka, MD, MAS, reminded an audience of internists at the 2025 ACP Internal Medicine meeting. An honest clinician-patient conversation about the choice will consider a patient's insurance coverage and available resources and will factor in relevant social determinants of health, Issaka said.

1 week ago | patientcareonline.com | Rachel Issaka |Grace Halsey

A novel proactive colorectal cancer (CRC) screening program that combined annual mailed fecal immunochemical testing (FIT) to eligible adults with on-request colonoscopy resulted in dramatic increases in screening compliance among both Black and White individuals in an ethnically diverse northern California population, according to data presented by Rachel Issaka, MD, MAS, at the ACP 2025 Internal Medicine Meeting.

1 week ago | patientcareonline.com | Rachel Issaka |Grace Halsey

Effective colorectal cancer screening programs are organized to tap expertise across specialties, Rachel Issaka, MD, MAS, told internists during her presentation at the 2025 ACP Internal Medicine Meeting in New Orleans.

2 weeks ago | patientcareonline.com | Rachel Issaka |Grace Halsey

Rachel Issaka, MD, MAS, associate professor of medicine and the Kathryn Surace-Smith endowed chair in health equity research at Fred Hutchinson Cancer Center shared a striking statistic in her presentation on colorectal cancer screening at the 2025 ACP Internal Medicine Meeting in New Orleans: approximately 76% of cancer deaths are attributable to a failure in screening, whether a complete failure to screen, failure to screen at the appropriate interval, or failure to follow-up properly after...

Mar 13, 2024 | eurekalert.org | Rachel Issaka

There are two statistics that Dr. Rachel Issaka would like people to seriously consider: In the last 30 years, the incidence of colorectal cancer has gone up by 50% for people under 50. By 2030, just six years from now, colorectal cancer is predicted to be the leading cause of cancer death for people under 50.